TussiCaps, which is approved by the FDA, is now available by prescription in 10mg/8mg capsules through wholesalers and pharmacies in the US.
TussiCaps extended-release capsules are indicated for the relief of cough and upper respiratory symptoms associated with allergies and colds.
Chuck Bramlage, president of pharmaceutical products at Covidien, said: “TussiCaps capsules offer patients a unique approach to handling the challenges of measuring liquid cough medications. Our commitment to increasing patient safety and helping to reduce the potential for dosing errors is demonstrated in TussiCaps, which offers more precise and convenient dosing than liquid formulations.”